Measurement Issues in the Use of Cognitive Neuroscience Tasks in Drug Development for Impaired Cognition in Schizophrenia: A Report of the Second Consensus Building Conference of the CNTRICS Initiative
Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4
Abstract
This overview describes the goals and objectives of the second conference conducted as part of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative. This second conference was informed by a series of online surveys and brought together basic and clinical scientists from academia and industry to address the concerns central to each field of research. Our goal was to develop recommendations for future research addressing the psychometric and practical challenges involved in translating paradigms from cognitive neuroscience into tasks that are feasible for use in the treatment discovery and development process. In this overview article, we describe the series of talks that were presentations at the conference. This article serves as an introduction to the set of articles included in this special issue that provide overviews and discussions of the issues raised and the recommendations made in these talks and in the subsequent discussions at the meeting. In addition, we describe the online surveys conducted in the month before the conference that were used to obtain suggestions from the field as to important task selection criteria and to generate initial benchmark goals for psychometric development for cognitive neuroscience tasks.
Authors and Affiliations
Deanna M. Barch, Cameron S. Carter, the CNTRICS Executive Committee
Keywords
Related Articles
- EP ID EP683273
- DOI 10.1093/schbul/sbn037
- Views 95
- Downloads 0
Using Event Related Potentials to Explore Stages of Facial Affect Recognition Deficits in Schizophrenia
Schizophrenia patients show impairments in identifying facial affect; however, it is not known at what stage facial affect processing is impaired. We evaluated 3 event-related potentials (ERPs) to explore stages of facia...
Pharmacological Interventions for Clozapine-induced Hypersalivation
Clozapine is widely used for people with schizophrenia. Agranulocytosis, weight gain, and cardiac problems are serious problems associated with clozapine use. Hypersalivation, sometimes of a gross and socially unacceptab...
Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework
The evolutionary origins of one of the most dramatic and seemingly deleterious behavioral phenotypes, the syndrome known as schizophrenia, are mysterious. Schizophrenia occurs in all cultures and is inherited. Although m...
Abnormal Superior Temporal Connectivity During Fear Perception in Schizophrenia
Patients with schizophrenia have difficulty in decoding facial affect. A study using event–related functional neuroimaging indicated that errors in fear detection in schizophrenia are associated with paradoxicall...
Psychosis Endophenotypes in Schizophrenia and Bipolar Disorder
Recent studies provide considerable evidence that schizophrenia and bipolar disorder may share overlapping etiologic determinants. Identifying disease-related genetic effects is a major focus in schizophrenia and bipolar...